JP2024543043A5 - - Google Patents

Info

Publication number
JP2024543043A5
JP2024543043A5 JP2024526901A JP2024526901A JP2024543043A5 JP 2024543043 A5 JP2024543043 A5 JP 2024543043A5 JP 2024526901 A JP2024526901 A JP 2024526901A JP 2024526901 A JP2024526901 A JP 2024526901A JP 2024543043 A5 JP2024543043 A5 JP 2024543043A5
Authority
JP
Japan
Prior art keywords
seq
cancer
tumors
polypeptide
bispecific polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543043A (ja
Filing date
Publication date
Priority claimed from GBGB2204539.7A external-priority patent/GB202204539D0/en
Priority claimed from GBGB2212801.1A external-priority patent/GB202212801D0/en
Application filed filed Critical
Priority claimed from PCT/EP2022/080861 external-priority patent/WO2023079102A2/en
Publication of JP2024543043A publication Critical patent/JP2024543043A/ja
Publication of JP2024543043A5 publication Critical patent/JP2024543043A5/ja
Pending legal-status Critical Current

Links

JP2024526901A 2021-11-05 2022-11-04 新規ペプチド Pending JP2024543043A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB2115925.6 2021-11-05
GB202115925 2021-11-05
GB2204539.7 2022-03-30
GBGB2204539.7A GB202204539D0 (en) 2022-03-30 2022-03-30 Novel peptides
GBGB2212801.1A GB202212801D0 (en) 2022-09-02 2022-09-02 Novel peptides
GB2212801.1 2022-09-02
PCT/EP2022/080861 WO2023079102A2 (en) 2021-11-05 2022-11-04 Novel peptides

Publications (2)

Publication Number Publication Date
JP2024543043A JP2024543043A (ja) 2024-11-19
JP2024543043A5 true JP2024543043A5 (cg-RX-API-DMAC7.html) 2025-11-13

Family

ID=84329469

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024526902A Pending JP2024542142A (ja) 2021-11-05 2022-11-04 新規ポリペプチド
JP2024526901A Pending JP2024543043A (ja) 2021-11-05 2022-11-04 新規ペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2024526902A Pending JP2024542142A (ja) 2021-11-05 2022-11-04 新規ポリペプチド

Country Status (9)

Country Link
US (4) US20260001961A1 (cg-RX-API-DMAC7.html)
EP (2) EP4426733A2 (cg-RX-API-DMAC7.html)
JP (2) JP2024542142A (cg-RX-API-DMAC7.html)
KR (2) KR20240099410A (cg-RX-API-DMAC7.html)
AU (1) AU2022381977A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237463A1 (cg-RX-API-DMAC7.html)
IL (1) IL312556A (cg-RX-API-DMAC7.html)
MX (1) MX2024005508A (cg-RX-API-DMAC7.html)
WO (2) WO2023079102A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260001961A1 (en) * 2021-11-05 2026-01-01 Alligator Bioscience Ab Novel polypeptides
JP2026515781A (ja) * 2023-04-13 2026-05-19 アリゲーター・バイオサイエンス・アーベー 併用療法
CN117924468B (zh) * 2023-12-08 2024-09-20 南京大学 一种靶向登革热病毒ns1蛋白纳米抗体的制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
LT2691417T (lt) 2011-03-29 2018-10-25 Roche Glycart Ag Antikūno fc variantai
GB201115280D0 (en) * 2011-09-05 2011-10-19 Alligator Bioscience Ab Antibodies, uses and methods
CA2980189A1 (en) * 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
CA3049791A1 (en) * 2017-01-27 2018-08-02 Silverback Therapeutics, Inc. Tumor targeting conjugates and methods of use thereof
EP3898681A2 (en) * 2018-12-17 2021-10-27 Alligator Bioscience AB Polypeptides
GB201820556D0 (en) 2018-12-17 2019-01-30 Alligator Bioscience Ab Novel polypeptides
AU2020357944A1 (en) * 2019-09-30 2022-03-31 Adimab, Llc CH1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the same
EP4048701A4 (en) 2019-10-23 2024-05-29 Lyvgen Biopharma Holdings Limited Anti-cd40 binding molecules and bi-specific antibodies comprising such
KR20220147583A (ko) * 2020-01-09 2022-11-03 바이오뮤넥스 파마슈티컬스 Mait 및 종양 세포 둘 모두에 결합하는 다중특이적 항체
US20260001961A1 (en) * 2021-11-05 2026-01-01 Alligator Bioscience Ab Novel polypeptides

Similar Documents

Publication Publication Date Title
Klein et al. The present and future of bispecific antibodies for cancer therapy
JP2019523630A5 (cg-RX-API-DMAC7.html)
JP2022515318A5 (cg-RX-API-DMAC7.html)
Chen et al. Bispecific antibodies in cancer immunotherapy
RU2018139339A (ru) Новые биспецифические полипептиды против cd137
TWI908779B (zh) 引導及導航控制(gnc)抗體樣蛋白質及製造與使用其之方法
JP2022537824A5 (cg-RX-API-DMAC7.html)
JP7600327B2 (ja) Pd-1とvegfを標的とした四価二重特異性抗体、その製造方法および用途
JP2022512891A5 (cg-RX-API-DMAC7.html)
JP2018525382A5 (cg-RX-API-DMAC7.html)
Luo et al. Design and applications of bispecific heterodimers: molecular imaging and beyond
JP2023510806A (ja) Mait及び腫瘍細胞の両方に結合する多重特異性抗体
JP2023534959A5 (cg-RX-API-DMAC7.html)
JP2024539630A5 (cg-RX-API-DMAC7.html)
JP2023523268A (ja) ヘテロダイマータンパク質
Hayashi et al. A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells
JP2019505545A5 (cg-RX-API-DMAC7.html)
WO2023217216A1 (zh) 一种三特异性抗体的设计、制备及用途
WO2021113748A1 (en) Composition of triaxial antibodies and method of making and using thereof
Hollander Bispecific antibodies for cancer therapy
Lee et al. Effective clearance of rituximab-resistant tumor cells by breaking the mirror-symmetry of immunoglobulin G and simultaneous binding to CD55 and CD20
Asano et al. Diabody-based recombinant formats of humanized IgG-like bispecific antibody with effective retargeting of lymphocytes to tumor cells
JP7505784B2 (ja) Gd2結合性分子
US20260055201A1 (en) Bispecific antibody and use thereof
CN120035449A (zh) 一种结合baffr和cd3的双特异性抗体及其应用